English  |  正體中文  |  简体中文  |  2875232  
???header.visitor??? :  54168862    ???header.onlineuser??? :  1722
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pu y s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 276-285 of 627  (63 Page(s) Totally)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-04T02:36:02Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2021-03-04T02:36:01Z Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; YU-CHIEH TSAI; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2021-03-04T02:36:01Z Down regulation of ABCD1 in human renal cell carcinoma Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; Huang C.-Y.; YU-CHIEH TSAI; Wu W.-J.; Huang S.-P.; Pu Y.-S.
臺大學術典藏 2021-03-04T02:36:00Z Down-regulation of PKC�a in renal cell carcinoma and its clinicopathological implications. Pu Y.S.; Huang C.Y.; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; Yu H.J.; Lai M.K.; YU-CHIEH TSAI; Wu W.J.; Hour T.C.
臺大學術典藏 2021-03-04T02:35:59Z Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma Yu-Chieh Tsai;Yeh C.-H.;Tzen K.-Y.;Ho P.-Y.;Tuan T.-F.;Pu Y.-S.;Cheng A.-L.;Cheng J.C.-H.; YU-CHIEH TSAI; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H.
臺大學術典藏 2021-03-04T02:35:59Z Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; YU-CHIEH TSAI; Pu Y.-S.; Chiang C.-K.; Liu S.-H.
臺大學術典藏 2021-03-04T02:35:58Z MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; YU-CHIEH TSAI; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H.
臺大學術典藏 2021-03-04T02:35:57Z MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; YU-CHIEH TSAI; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H.
臺大學術典藏 2021-03-04T02:35:57Z Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; Tsai C.-L.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H.
臺大學術典藏 2021-03-04T02:35:57Z Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma Hu C.-Y.; YU-CHIEH TSAI; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; Lin W.-C.; Huang K.-H.

Showing items 276-285 of 627  (63 Page(s) Totally)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
View [10|25|50] records per page